Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer Grant US-11419927-B2 United States of America 23 Aug 2022
Vaccines against antigens involved in therapy resistance and methods of using same Grant US-11235043-B2 United States of America 01 Feb 2022
Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the… Grant US-11224665-B2 United States of America 18 Jan 2022
Vaccines against an oncogenic isoform of ESR1 and methods of using the same Grant US-10842855-B2 United States of America 24 Nov 2020
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same Grant US-10842857-B2 United States of America 24 Nov 2020
Vaccines against HER3 antigens and methods of using the same Grant US-10487143-B2 United States of America 26 Nov 2019
VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME Application EP-3166630-A4 European Patent Office 28 Mar 2018
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ERBB2) AND METHODS OF USING THE SAME Application EP-3166646-A4 European Patent Office 07 Mar 2018
A VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN TREATING CANCER Application WO-2017207814-A1 World Intellectual Property Organisation (WIPO) 07 Dec 2017
ANTI-TUMOR ANTIBODIES AS PREDICTIVE OR PROGNOSTIC BIOMARKERS OF EFFICACY AND SURVIVAL IN… Application WO-2013169971-A1 World Intellectual Property Organisation (WIPO) 14 Nov 2013